Here, Feng et al. investigated the molecular mechanisms underlying the responses to immunotherapy in renal cancer by loss of PBRM1, a subunit of the PBAF (SWI/SNF) chromatin remodeling complex mutated in ∼40% of clear cell renal cancers. This evidence concerns the gene PBRM1 and renal carcinoma.